Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 14, 2022 - Issue
Submit an article Journal homepage
262
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

Wendy Y Cheng1 Analysis Group, Inc., Boston, MA, USACorrespondence[email protected]
,
Sujata P Sarda2 Apellis Pharmaceuticals, Inc., Waltham, MA, USA
,
Nikita Mody-Patel2 Apellis Pharmaceuticals, Inc., Waltham, MA, USA
,
Sangeeta Krishnan2 Apellis Pharmaceuticals, Inc., Waltham, MA, USA
,
Mihran Yenikomshian1 Analysis Group, Inc., Boston, MA, USA
,
Colin Kunzweiler1 Analysis Group, Inc., Boston, MA, USA
,
Jensen Duy Vu1 Analysis Group, Inc., Boston, MA, USA
,
Hoi Ching Cheung1 Analysis Group, Inc., Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-7651-4903
ORCID Icon &
Mei Sheng Duh1 Analysis Group, Inc., Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-5035-6687
ORCID Icon show all
Pages 357-369 | Published online: 03 May 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Flore Sicre de Fontbrune, Pascale Burmester, Maria Piggin, Joana E. Matos, Halley Costantino, Koo Wilson, Zalmai Hakimi, Jameel Nazir, Renaud Desgraz, Jesse Fishman, Emmelie Persson & Jens Panse. (2022) The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors: clinical outcomes and medical encounters from the patient perspective. Hematology 27:1, pages 1140-1151.
Read now

Articles from other publishers (3)

Kelly C. BroderickJames P. BurkeJesse FishmanPatrick P. Gleason. (2023) Descriptive, real-world treatment patterns, resource use, and total cost of care among eculizumab- and ravulizumab-treated members with paroxysmal nocturnal hemoglobinuria. Journal of Managed Care & Specialty Pharmacy 29:8, pages 941-951.
Crossref
Katharina Versmold, Ferras Alashkar, Carina Raiser, Richard Ofori‐Asenso, Tao Xu, Yutong Liu, Pablo Katz, Aijing Shang & Alexander Röth. (2023) Long‐term outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in a real‐world setting . European Journal of Haematology.
Crossref
Jens Panse, Flore Sicre de Fontbrune, Pascale Burmester, Maria Piggin, Joana E. Matos, Halley Costantino, Koo Wilson, Zalmai Hakimi, Jameel Nazir, Renaud Desgraz, Jesse Fishman, Emmelie Persson & Austin Kulasekararaj. (2022) The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient‐reported insights on symptoms and quality of life . European Journal of Haematology 109:4, pages 351-363.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.